Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism MCT1 inhibitors(Monocarboxylate transporter 1 inhibitors), MCT4 inhibitors(solute carrier family 16 member 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mouth Neoplasms | Preclinical | United States | 30 Apr 2025 |